Drug Trial Radar · NCT00538343
RTA 744 in Breast Cancer Patients With Progression of Previously Irradiated Brain Metastases
Last checked: Nov 19, 2026Latest source record: May 29, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
14
Actual
Start
Oct 31, 2007
Primary completion
Dec 1, 2008
Study completion Jan 1, 2009
Sponsor
- Lead sponsor
- BiogenBiogen (BIIB)
- Sponsor type
- Industry
- First posted
- Oct 2, 2007
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether RTA 744 is effective in the treatment of breast cancer that has metastasized to the brain.
Conditions
- Brain Metastases
Interventions
berubicin hydrochloride (RTA 744)Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- To evaluate the efficacy of RTA 744 in reducing intracranial tumor on contrast-enhanced MRI of breast cancer patients with progression of brain metastases following whole brain radiotherapy (WBRT).Time frame: 21 Days
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Palm Beach Cancer Institute
West Palm Beach, Florida
Presbyterian Health Care
Charlotte, North Carolina
Duke University Medical Center
Durham, North Carolina
Moses Cone Regional Cancer Center
Greensboro, North Carolina
Forsyth Regional Cancer Center
Winston-Salem, North Carolina
Texas Oncology, PA
Dallas, Texas
Virginia Oncology Associates
Newport News, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.